Management of patients treated with chemoradiotherapy for head and neck cancer without prophylactic feeding tubes: The University of Pittsburgh experience

Laryngoscope

Volumn 120, Issue 1, 2010, Pages 71-75

  McLaughlin, Brian T ^a   Gokhale, Abhay S ^a   Shuai, Yongli ^b   Diacopoulos, Joyce ^a   Carrau, Ricardo ^a,c   Heron, Dwight E ^a   Smith, Ryan P ^a   Gibson, Michael K ^a   Ferris, Robert L ^a,c   Grandis, Jennifer R ^a,c   Johnson, Jonas T ^a,c   Argiris, Athanassios ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Chemoradiotherapy; Gastrostomy tube; Head and neck cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; PACLITAXEL; PEMETREXED;

ADULT; AGED; ARTICLE; DYSPHAGIA; FEEDING APPARATUS; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; STOMACH TUBE; WEIGHT REDUCTION; DIGESTIVE TRACT INTUBATION; HEAD AND NECK TUMOR; MIDDLE AGED;

ADULT; AGED; COMBINED MODALITY THERAPY; DEGLUTITION DISORDERS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INTUBATION, GASTROINTESTINAL; MALE; MIDDLE AGED; MUCOSITIS; RADIOTHERAPY DOSAGE;

EID: 74049142052     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20697     Document Type: Article

References (20)

1. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet 2008;371:1695-1709.
2. Trotti LA, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003;66:253-262.
3. Rosenthal DI, Lewin JS, Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol 2006;24: 2636-2643.
4. Cady J. Nutritional support during radiotherapy for head and neck cancer: the role of prophylactic feeding tube placement. Clin J Oncol Nurs 2007;11:875-880.
5. Rustom IK, Jebreel A, Tayyab M, England RJ, Stafford ND. Percutaneous endoscopic, radiological, and surgical gastrostomy tubes: a comparison in head and neck cancer patients. J Laryngol Otol 2006;10:463-466.
6. Nguyen NP, North D, Smith HJ, et al. Safety and effectiveness of prophylactic gastrostomy tubes for head and neck cancer patients undergoing chemoradiation. Surgical Oncol 2006;15:199-203.
7. Lee JH, Machtay M, Unger LD, et al. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998;124:871-875.
8. Wiggenraad RGJ, Flierman L, Goossens A, et al. Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer. Clin Otoaryngol 2007;32: 384-390.
9. Gillespie MB, Brodsky MA, Day TA, Lee FS, Martin-Harris B. Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope 2004;114:1362-1367.
10. Gokhale A, McLaughlin BT, Flickinger JC, et al. Clinical and dosimetric factors associated with a prolonged feeding tube requirement in patients treated with chemoradiotherapy (CRT) for head and neck cancers. Ann Oncol 2009 Jul 14. Epub ahead of print.
11. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008;26:3582-3589.
12. Goguen LA, Posner MR, Norris CM, et al. Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer. Otolaryngol Head Neck Surg 2006;134: 916-922.
13. Shiley S, Hargunani CA, Skoner JM, Holland JM, Wax MK. Swallowing function after chemoradiation for advanced stage oropharyngeal cancer. Otolaryngol Head Neck Surg 2006;134:455-459.
14. Baredes S, Behin D, Deitch E. Percutaneous endoscopic gastrostomy tube feeding in patients with head and neck cancer. Ear Nose Throat J 2004;83:417-419.
15. Logemann J, Rademaker AW, Pauloski BR, et al. Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head Neck 2006;28:64-73.
16. Lazarus C, Logemann JA, Pauloski BR, et al. Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer. Head Neck 2007;29:632-637.
17. Rieger JM, Zalmanowitz JG, Wolfaardt JF. Functional outcomes after organ preservation treatment in head and neck cancer: a critical review of the literature. Int J Oral Maxillofac Surg 2006;35:581-587.
18. Akst LM, Chan J, Elson P, Saxton J, Strome M, Adelstein D. Functional outcomes following chemoradiotherapy for head and neck cancer. Otolaryngol Head Neck Surg 2004; 131:950-957.
19. Agarwala SS, Cano E, Heron DE, et al. Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neck cancer. Ann Oncol 2007;18:1224-1229.
20. Choong N, Vokes E. Expanding role of the medical oncologist in the management of head and neck cancer. CA Cancer J Clin 2008;58:32-53.